Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02409056
Other study ID # UGeorgia
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2015
Est. completion date February 28, 2020

Study information

Verified date June 2020
Source University of Georgia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project is the test of the effectiveness of the Chronic Disease Self-Management Program which will be translated to a worksite setting.


Description:

This project will test adaptations of the Chronic Disease Self-Management Program (CDSMP) designed to increase the likelihood of widespread use in workplace settings. CDSMP, which has been proven efficacious in community trials, is a six-week program that is designed to help individuals better manage their chronic disease and its many complications. Although there is considerable interest among worksite health promotion practitioners for a chronic disease program, CDSMP has not been adapted and tested in workplace settings. In this study, we will determine a) if the CDSMP program tailored to worksites can be efficacious, b) the comparative effectiveness of the worksite tailored CDSMP when compared to the original CDSMP and c) the cost-effectiveness (average and incremental) and return on investment of the two interventions. The participating sites are seven organizations from a rural county in Southwest Georgia. Our partner for the project is the local YMCA. YMCA staff will be trained to implement the program which will foster sustainability. Participants will be randomly assigned to 1) workplace-tailored CDSMP, 2) 'usual care' CDSMP, and 3) control group. Data will collected at baseline, 6-month follow-up and 12-months follow-up. The control group will be a delayed intervention group that will be randomly assigned to an intervention group after taking the 6 month survey. The primary outcome measures include blood pressure, cholesterol, blood glucose, BMI, diet, physical activity and tobacco use and the secondary measures including patient-provider communication, quality of life, medical adherence, and work performance and productivity. An average cost-effectiveness analysis will compare interventions to control and an incremental cost-effectiveness analysis will be conducted comparing each intervention to one another. The hypotheses will be tested using a growth modeling approach examining changes over time. This will enable us to maximize the dissemination and implementation of CDSMP across worksite populations by using approaches which are realistic for most work organizations.


Recruitment information / eligibility

Status Completed
Enrollment 800
Est. completion date February 28, 2020
Est. primary completion date November 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- The primary target is all employees 45 years or above with levels of gender and ethnicity similar to those found in the workplaces with which we will work.

- If younger individuals wish to participate, we will not turn them away but the program is designed for older adults. It is unlikely we will get a substantial number of participants over 45.

Exclusion Criteria:

- None

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Workplace-tailored CDSMP
This is the CDSMP program which has been modified to fit the unique characteristics of the workplace and will be offered in worksites.
Chronic Disease Self-Management Program
This is the standard CDSMP which has been implemented in community settings.

Locations

Country Name City State
United States Madison County Schools Danielsville Georgia
United States City of Moultrie Moultrie Georgia
United States Colquitt County Government Moultrie Georgia
United States Colquitt County Schools Moultrie Georgia
United States Colquitt Regional Medical Center Moultrie Georgia
United States National Beef Moultrie Georgia
United States Southwest Georgia Bank Moultrie Georgia
United States Southwest Georgia Community Action Council Moultrie Georgia
United States Southwest Regional Technical College Moultrie Georgia
United States Turning Point Hospital Moultrie Georgia
United States Lowndes County Valdosta Georgia
United States Valdosta City Schools Valdosta Georgia
United States Wiregrass Technical College Valdosta Georgia

Sponsors (2)

Lead Sponsor Collaborator
University of Georgia YMCA

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Absenteeism scale examining change at 6 and 12 months Measures absence, lateness, and performance. baseline, six months, one year
Other Presenteeism (Work Limitations Questionnaire (WLQ) examining change at 6 and 12 months Work Limitations Questionnaire (WLQ) assess the degree to which health problems interfered with job activities. baseline, six months, one year
Other Work ability index examining change at 6 and 12 months Assess physical and mental demands of work and worker's health status and resources. baseline, six months, one year
Other Job satisfaction question examining change at 6 and 12 months Measures job satisfaction. baseline, six months, one year
Other Organizational commitment scale examining change at 6 and 12 months Measures organizational commitment. baseline, six months, one year
Other Turnover intention question examining change at 6 and 12 months Measures likelihood of leaving the organization. baseline, six months, one year
Other Job stress scale examining change at 6 and 12 months Measures job-related stress. baseline, six months, one year
Other Fatigue (Work-related fatigue assessment scale.) examining change at 6 and 12 months Work-related fatigue assessment scale. baseline, six months, one year
Other Healthcare utilization (Self-report measures) examining change at 6 and 12 months Self-report measures of physician and hospital services. baseline, six months, one year
Primary Body Mass Index examining change at 6 and 12 months Measure of obesity using height and weight baseline, six months, one year
Primary blood pressure examining change at 6 and 12 months diastolic and systolic measures baseline, six months, one year
Primary Cholesterol levels examining change at 6 and 12 months HDL, LDL, and total cholesterol levels baseline, six months, one year
Primary blood glucose examining change at 6 and 12 months blood glucose levels baseline, six months, one year
Primary Cardiovascular risk scale examining change at 6 and 12 months Overall measure taken from the Framing Heart Study which includes: systolic blood pressure, total cholesterol, HDL cholesterol, BMI, gender, age, use of antihypertensive treatment, smoking and diabetes mellitus status. baseline, six months, one year
Primary Eating behaviors (Food propensity questionnaire) examining change at 6 and 12 months Food propensity questionnaire used to estimate usual intake for food items and food groups. baseline, six months, one year
Primary Physical activity (Measure of moderate-intensity physical activities) examining change at 6 and 12 months Measure of moderate-intensity physical activities. baseline, six months, one year
Primary Sedentary behavior (Measures total time spent sitting in transport, work and leisure) examining change at 6 and 12 months Measures total time spent sitting in transport, work and leisure. baseline, six months, one year
Primary Tobacco use examining change at 6 and 12 months Measure of current and past tobacco use. baseline, six months, one year
Secondary Patient-provider communication (Measure of communication with a physician) examining change at 6 and 12 months Measure of communication with a physician. baseline, six months, one year
Secondary Self-assessed quality of life scale examining change at 6 and 12 months CDC Healthy Days quality of life measure. baseline, six months, one year
Secondary Depression (Personal Health Questionnaire Depression Scale (PHQ8) examining change at 6 and 12 months Personal Health Questionnaire Depression Scale (PHQ8). baseline, six months, one year
Secondary Prescription medication adherence examining change at 6 and 12 months Measures medication compliance. baseline, six months, one year
Secondary Pain (Visual analogue scale) examining change at 6 and 12 months Visual analogue scale to determine symptoms of chronic disease. baseline, six months, one year
Secondary Sleep (Visual analogue scale) examining change at 6 and 12 months Visual analogue scale to determine symptoms of chronic disease. baseline, six months, one year
Secondary Stress (Visual analogue scale) examining change at 6 and 12 months Visual analogue scale to determine symptoms of chronic disease. baseline, six months, one year
Secondary Fatigue (Visual analogue scale) examining change at 6 and 12 months Visual analogue scale to determine symptoms of chronic disease. baseline, six months, one year
Secondary Well-being (SF-12) scale examining change at 6 and 12 months Measure of functional health and well-being (SF-12). baseline, six months, one year
Secondary Quality of life (EQ-5D) scale examining change at 6 and 12 months Measure of quality of life (EQ-5D). baseline, six months, one year
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)